心理治疗没有比抗抑郁药更有效, 研究发现, 有可能由于未盲目的试验设计的好处. Psychedelic therapy no more effective than antidepressants, study finds, with benefits likely due to unblinded trial design.

一项新的研究发现, 迷幻药辅助治疗对抑郁症的疗效不比传统抗抑郁药更高. 研究人员认为早期感知到的好处是由于试验中没有盲目的结果. A new study finds psychedelic-assisted therapy is no more effective than traditional antidepressants for treating depression, with researchers attributing earlier perceived benefits to the lack of blinding in trials. 心理学家们对心理乱药的试验与非标抗抑郁剂研究进行了比较, 在52分尺度上发现差异仅为0.3个点. Comparing psychedelic trials to open-label antidepressant studies, scientists observed only a 0.3-point difference on a 52-point scale—clinically insignificant. 这项由加州大学旧金山分校, UCLA 和伦敦帝国理工学院的研究人员领导的研究表明,知道自己正在接受有效治疗可能会增加结果,特别是在安慰剂方面. The study, led by researchers from UC San Francisco, UCLA, and Imperial College London, suggests that knowing one is receiving an active treatment may inflate results, particularly for placebos. 虽然这两种方法都提高了抑郁症的评分, 大约12个点, 但这些发现挑战了迷幻药优越性的说法, 并强调需要更严格的盲目的试验来确定真正有效性. While both approaches improved depression scores by about 12 points, the findings challenge claims of psychedelic superiority and highlight the need for more rigorous, blinded trials to determine true effectiveness.